| Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury | journal | January 2009 | 
    | Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? | journal | February 2010 | 
    | Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity | journal | August 2013 | 
    | Quantification of cells cultured on 96-well plates | journal | October 1989 | 
    | Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture | journal | December 2008 | 
    | Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs | journal | July 2011 | 
    | What do I need to know about immunoglobulin light chain (AL) amyloidosis? | journal | July 2012 | 
    | Thermodynamic Instability of Human λ6 Light Chains:  Correlation with Fibrillogenicity † | journal | October 1999 | 
    | Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture | journal | November 2010 | 
    | An in vitro model of light chain deposition disease | journal | March 2009 | 
    | The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes | journal | January 2012 | 
    | Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes | journal | February 2013 | 
    | p38 Kinase Is Activated in the Alzheimer's Disease Brain | journal | May 1999 | 
    | Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture | journal | February 2004 | 
    | Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38  MAPK pathway | journal | February 2010 | 
    | In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides | journal | August 2011 | 
    | A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro | journal | July 2000 | 
    | A role for destabilizing amino acid replacements in light-chain amyloidosis. | journal | June 1994 | 
    | Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay | journal | January 2008 | 
    | The Mitochondrial Uncoupling Agent 2,4-Dinitrophenol Improves Mitochondrial Function, Attenuates Oxidative Damage, and Increases White Matter Sparing in the Contused Spinal Cord | journal | October 2004 | 
    | The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein | journal | July 2006 | 
    | Mutational and genetic determinants of λ6 light chain amyloidogenesis | journal | October 2013 | 
    | Amyloid diseases of the heart: assessment, diagnosis, and referral | journal | December 2010 | 
    | Systemic Amyloidoses | journal | June 2013 | 
    | Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells | journal | January 2007 | 
    | Current perspectives on cardiac amyloidosis | journal | February 2012 | 
    | Infusion of Light Chains From Patients With Cardiac Amyloidosis Causes Diastolic Dysfunction in Isolated Mouse Hearts | journal | October 2001 | 
    | Diagnosis and Management of the Cardiac Amyloidoses | journal | September 2005 | 
    | Cardiac Amyloidosis | journal | September 2012 | 
    | Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL | journal | May 2006 | 
    | TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells | journal | February 2014 | 
    | Amyloidosis: Pathogenesis and New Therapeutic Options | journal | May 2011 | 
    | Amyloid heart disease | journal | February 2010 | 
    | AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils | journal | December 2012 | 
    | Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit | journal | January 2003 | 
    | Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease? | journal | December 2012 | 
    | Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vλ6 proteins | journal | June 2004 | 
    | Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury | journal | January 2009 | 
    | Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? | journal | February 2010 | 
    | Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity | journal | August 2013 | 
    | Quantification of cells cultured on 96-well plates | journal | October 1989 | 
    | A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate | journal | November 1992 | 
    | Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture | journal | December 2008 | 
    | Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs | journal | July 2011 | 
    | What do I need to know about immunoglobulin light chain (AL) amyloidosis? | journal | July 2012 | 
    | Systemic and microvascular oxidative stress induced by light chain amyloidosis | journal | November 2010 | 
    | Thermodynamic and Kinetic Characterization of a Germ Line Human λ6 Light-Chain Protein: The Relation between Unfolding and Fibrillogenesis | journal | March 2009 | 
    | Novel cell lines derived from adult human ventricular cardiomyocytes | journal | July 2005 | 
    | Thermodynamic Instability of Human λ6 Light Chains:  Correlation with Fibrillogenicity † | journal | October 1999 | 
    | Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture | journal | November 2010 | 
    | An in vitro model of light chain deposition disease | journal | March 2009 | 
    | Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns | journal | March 2004 | 
    | The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes | journal | January 2012 | 
    | Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes | journal | February 2013 | 
    | p38 Kinase Is Activated in the Alzheimer's Disease Brain | journal | May 1999 | 
    | Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture | journal | February 2004 | 
    | Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38  MAPK pathway | journal | February 2010 | 
    | In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides | journal | August 2011 | 
    | A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro | journal | July 2000 | 
    | Thermodynamic Modulation of Light Chain Amyloid Fibril Formation | journal | January 2000 | 
    | Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay | journal | January 2008 | 
    | The Mitochondrial Uncoupling Agent 2,4-Dinitrophenol Improves Mitochondrial Function, Attenuates Oxidative Damage, and Increases White Matter Sparing in the Contused Spinal Cord | journal | October 2004 | 
    | The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein | journal | July 2006 | 
    | Mutational and genetic determinants of λ6 light chain amyloidogenesis | journal | October 2013 | 
    | Comparison of the effect of a mitochondrial uncoupler, 2,4-dinitrophenol and adrenaline on oxygen radical production in the isolated perfused rat liver | journal | June 1992 | 
    | Amyloid diseases of the heart: assessment, diagnosis, and referral | journal | December 2010 | 
    | Systemic Amyloidoses | journal | June 2013 | 
    | Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells | journal | January 2007 | 
    | Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins | journal | December 2011 | 
    | Current perspectives on cardiac amyloidosis | journal | February 2012 | 
    | Human Amyloidogenic Light Chains Directly Impair Cardiomyocyte Function Through an Increase in Cellular Oxidant Stress | journal | April 2004 | 
    | Diagnosis and Management of the Cardiac Amyloidoses | journal | September 2005 | 
    | Cardiac Amyloidosis | journal | September 2012 | 
    | Infusion of Light Chains From Patients With Cardiac Amyloidosis Causes Diastolic Dysfunction in Isolated Mouse Hearts | journal | October 2001 | 
    | Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL | journal | May 2006 | 
    | Radioimmunodetection of amyloid deposits in patients with AL amyloidosis | journal | September 2010 | 
    | TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells | journal | February 2014 | 
    | Amyloidosis: Pathogenesis and New Therapeutic Options | journal | May 2011 | 
    | Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis | journal | May 2008 | 
    | Amyloid heart disease | journal | February 2010 | 
    | AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils | journal | December 2012 | 
    | Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit | journal | January 2003 | 
    | The diagnosis and typing of cardiac amyloidosis | journal | January 2003 | 
    | Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease? | journal | December 2012 |